Acute intoxication with methotrexate, used as an abortive, has not been des
cribed in Chile. We report two females patients, aged 15 and 24 years old,
who presented with mucositis, erythrodermia, pancytopenia, and elevation of
hepatic enzymes. Plasma methotrexate levels confirms the clinical diagnosi
s and both patients were treated with high leucovorin doses and management
of associated complications. In one patient, pregnancy continued, giving bi
rth to a newborn with cranial, face and limb malformation. The second patie
nt had a late rescue with leucovorin and was discharged with a persistent s
ensory motor neuropathy. Considering the severity of complications and that
patients may deny its use, when there is reasonable clinical suspicion of
methotrexate intoxication, leucovorin treatment should be started.